Skip to main content
. Author manuscript; available in PMC: 2023 Nov 20.
Published in final edited form as: Ann Rheum Dis. 2020 Oct 8;80(3):286–292. doi: 10.1136/annrheumdis-2020-218282

Table 4.

Trajectory of multimorbidity in incident rheumatoid arthritis (RA) compared to non-RA patients

A. Primary analysis
(n=44 conditions)
B. Secondary analysisa
(n=36 conditions)
C. 2 years pre-index date
(n=44 conditions)
β (95% CI) P β (95% CI) P β (95% CI) P
RA vs. non-RA 1.13 (1.10, 1.17) <0.001 0.62 (0.59, 0.64) <0.001 0.29 (0.27, 0.31) <0.001
Year of follow-up 0.24 (0.23, 0.24) <0.001 0.18 (0.18, 0.19) <0.001 0.48 (0.47, 0.49) <0.001
RA x time (years) 0.21 (0.20, 0.21) <0.001 0.12 (0.11, 0.13) <0.001 0.33 (0.32, 0.35) <0.001
Age (per year) 0.06 (0.06, 0.06) <0.001 0.05 (0.05, 0.05) <0.001 0.04 (0.04, 0.04) <0.001
Female sex 0.28 (0.24, 0.32) <0.001 0.15 (0.12, 0.18) <0.001 0.16 (0.12, 0.20) <0.001
a

Excluded conditions known to be related to RA or could be misclassified as RA

A & B. N=61,528 patients and 173,469 observations

C. N=33,202 patients and 153,121 observations